Corvel Corp Dossier - Source-backed chat

Corvel Corp

CRVLNASDAQ

SectorFinancials

IndustryInsurance Brokers

Beta (adjusted)0.97

Intrinsic Value $91.27median of 2 methodsbased on filings through 30 Jun 2026

Market Price $74.72Price as of 1 Oct 2026

UndervaluedIntrinsic value is 22% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $3.8B

Shares Outstanding 50.6M diluted

Next Earnings Date3 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

CorVel Corporation (NASDAQ: CRVL) is a highly disciplined, technology-enabled defensive compounder operating in the workers' compensation and healthcare cost containment markets. The company's proprietary CareMC platform and CERIS payment integrity division are driving strong operational efficiencies, supported by aggressive integration of agentic AI and workflow automation. CorVel maintains a fortress balance sheet with $233 million in cash and zero debt, allowing it to consistently fund share repurchases entirely from operating cash flow. Despite short-term market headwinds such as declining work-related injury volumes, CorVel's ability to capture market share and manage severe medical inflation positions it for long-term double-digit earnings growth.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Severe medical inflation outpaces CorVel's cost containment capabilities, or work-related injury volumes decline more sharply than expected. Enterprise implementations for large payers face delays, slowing down CERIS revenue growth. Increased competition in healthcare payment integrity pressures pricing.

Base CaseCentral scenario

CorVel continues to execute on its technology-driven cost containment strategy, expanding its market share in workers' compensation and scaling its CERIS payment integrity platform. Operating margins remain stable or expand slightly to 15-16% due to AI-driven workflow automation. Share buybacks continue to reduce outstanding share count, supporting double-digit EPS growth.

Scenarios reflect our research view at the research date.

Key Investment Merits

Fortress balance sheet with $233 million in cash and zero long-term debt.
Consistent track record of capital return, having repurchased approximately 69% of outstanding shares since program inception funded entirely by operating cash flow.
Strong competitive moat driven by proprietary CareMC and CERIS platforms integrated with advanced AI, machine learning, and natural language processing.
Defensive business model with low cyclicality, as employers prioritize cost control and payment accuracy across economic cycles.

Key Investment Risks

Long-term structural decline in overall work-related injury volumes.
Workers' compensation programs continue to face pressure from rising litigation, wage growth, and medical costs, with CorVel's book-of-business data showing a 9.6% increase in litigation, a 5.9% rise in average weekly wage, and a 5.6% increase in average compensation.
Execution risk associated with the upcoming transition of Sarah Scott to CEO and President on July 1, 2026.

Thesis Invalidation Triggers

Deceleration of annual revenue growth to low single digits.
Significant contraction in operating margins below 13% due to rising technology or labor costs.
Failure to successfully onboard and scale major enterprise payer accounts within the CERIS division.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.